TY - JOUR AU - Schmelz, Renate AU - Bornhäuser, Martin AU - Schetelig, Johannes AU - Kiani, Alexander AU - Platzbecker, Uwe AU - Schwanebeck, Uta AU - Grählert, Xina AU - Uharek, Lutz AU - Aust, Daniela AU - Baretton, Gustavo AU - Schwerdtfeger, Rainer AU - Hampe, Jochen AU - Greinwald, Roland AU - Mueller, Ralph AU - Ehninger, Gerhard AU - Miehlke, Stephan PY - 2014 DA - 2014/11/26 TI - Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST) JO - BMC Gastroenterology SP - 197 VL - 14 IS - 1 AB - Gastrointestinal graft–versus-host disease (GvHD) is a potentially life-threatening complication after allogeneic stem cell transplantation (SCT). Since therapeutic options are still limited, a prophylactic approach seems to be warranted. SN - 1471-230X UR - https://doi.org/10.1186/s12876-014-0197-7 DO - 10.1186/s12876-014-0197-7 ID - Schmelz2014 ER -